Standard BioTools
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Standard BioTools's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9% to $106,340,000. The net income raised on -$74,656,000 and profit margin reached -70%. Total operating expenses were $113,489,000.
Profit Margin
| 2014 | 116.45M | -52.83M | -45.36% |
|---|---|---|---|
| 2015 | 114.71M | -53.31M | -46.48% |
| 2016 | 104.44M | -75.98M | -72.75% |
| 2017 | 101.93M | -60.53M | -59.38% |
| 2018 | 112.96M | -59.01M | -52.24% |
| 2019 | 117.24M | -64.79M | -55.26% |
| 2020 | 138.14M | -53.02M | -38.38% |
| 2021 | 130.58M | -59.23M | -45.36% |
| 2022 | 97.94M | -190.09M | -194.08% |
| 2023 | 106.34M | -74.65M | -70.21% |
FLDM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 106.34M | 97.94M | 130.58M | 138.14M | 117.24M | 112.96M | 101.93M | 104.44M | 114.71M | 116.45M |
Cost of revenue | 55.89M | 60.89M | 61.20M | 54.81M | 52.96M | 51.31M | 49.95M | 46.00M | 46.63M | 42.84M |
Gross profit | 50.45M | 37.05M | 69.37M | 83.32M | 64.27M | 61.64M | 51.98M | 58.43M | 68.08M | 73.60M |
Operating exp. | ||||||||||
Research and development | 25.94M | 38.49M | 37.94M | 36.46M | 31.64M | 30.03M | 30.82M | 38.41M | 39.26M | 43.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 113.48M | 153.25M | 136.83M | 134.36M | 116.11M | 109.81M | 110.34M | 131.62M | 122.22M | 114.74M |
Operating income | -76.6M | -116.20M | -67.45M | -51.03M | -51.83M | -48.16M | -58.36M | -73.19M | -50.15M | -51.83M |
Other income (expenses), net | 2.39M | -76.72M | 3.79M | -3.06M | -14.86M | 637K | -5.43M | -1.16M | -4.63M | -5.86M |
Income before tax | -74.20M | -192.92M | -63.66M | -54.10M | -66.70M | -61.42M | -63.79M | -80.17M | -54.79M | -57.70M |
Income tax expense | 452K | -2.83M | -4.42M | -1.08M | -1.91M | -2.40M | -3.26M | -4.19M | -1.47M | -4.87M |
Net income | -74.65M | -190.09M | -59.23M | -53.02M | -64.79M | -59.01M | -60.53M | -75.98M | -53.31M | -52.83M |
Earnings per share | ||||||||||
Basic EPS | -0.94 | -2.43 | -0.78 | -0.74 | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 | -1.9 |
Diluted EPS | -0.94 | -2.43 | -0.78 | -0.74 | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 | -1.9 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |